Kidney Mesenchymal Stem Cell Differentiation: Effect of Scaffold and Basic Fibroblast Growth Factor

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Nephrology

Background:

• Chronic kidney disease (CKD) is a global health issue requiring novel treatments for end-stage renal disease (ESRD).
• Organ transplantation, while effective, faces limitations like immune rejection and donor scarcity.
• Tissue engineering offers a promising alternative for kidney regeneration.

Purpose of the Study:

• To create and evaluate a decellularized rat kidney scaffold for tissue engineering applications.
• To assess the potential of kidney mesenchymal stem cells (kMSCs) for recellularizing the scaffold.
• To investigate the expression of renal-specific markers following kMSC differentiation within the scaffold.

Main Methods:

• Rat kidneys were decellularized to create a 3D scaffold, preserving native architecture.
• Decellularization efficiency was confirmed via histological and scanning electron microscopy analyses.
• Scaffolds were recellularized with kMSCs, and cell behavior and renal marker gene expression (Wt-1, ZO-1, AQP-1, ANG-1) were analyzed over time using qRT-PCR.

Main Results:

• Decellularized scaffolds maintained their 3D structure.
• kMSCs successfully adhered, proliferated, and infiltrated the scaffold in a time-dependent manner.
• Significant upregulation of renal-specific markers was observed, indicating successful kMSC differentiation. Basic fibroblast growth factor (bFGF) enhanced gene expression.

Conclusions:

• Preserving scaffold 3D architecture during decellularization is crucial for optimal cellular response.
• Recellularized scaffolds with kMSCs show potential for kidney tissue regeneration.
• This approach offers a promising avenue for developing alternative therapies for kidney failure.